UNC1999
目录号: PL14921 纯度: ≥99%
CAS No. :1431612-23-5
商品编号 规格 价格 会员价 是否有货 数量
PL14921-5mg 5mg ¥1147.00 请登录
PL14921-10mg 10mg ¥1793.00 请登录
PL14921-50mg 50mg ¥5381.00 请登录
PL14921-100mg 100mg ¥9627.00 请登录
PL14921-200mg 200mg 询价 询价
PL14921-500mg 500mg 询价 询价
PL14921-10mM*1mLinDMSO 10mM*1mLinDMSO ¥1438.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
UNC1999
中文别名
N-[(1,2-二氢-6-甲基-2-氧代-4-丙基-3-吡啶基)甲基]-1-(1-甲基乙基)-6-[6-[4-(1-甲基乙基)-1-哌嗪基]-3-吡啶基]-1H-吲唑-4-甲酰胺;UNC1999 抑制剂
英文名称
UNC1999
英文别名
UNC1999;N-[(6-methyl-2-oxo-4-propyl-1H-pyridin-3-yl)methyl]-1-propan-2-yl-6-[6-(4-propan-2-ylpiperazin-1-yl)pyridin-3-yl]indazole-4-carboxamide;S7165;UNC-1999;1-Isopropyl-6-(6-(4-isopropylpiperazin-1-yl)pyridin-3-yl)-N-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)-1H-indazole-4-carboxamide;UNC 1999;N-[(1,2-Dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[6-[4-(1-methylethyl)-1-piperazinyl]-3-pyridinyl]-1H-indazole-4-carboxamide;GTPL8237
Cas No.
1431612-23-5
分子式
C33H43N7O2
分子量
569.74
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
UNC1999 是一种有效,选择性和SAM-竞争性的 EZH2 和 EZH1 抑制剂,IC50 分别为 <10 nM 和 45 nM。
生物活性
UNC1999 is a SAM-competitive, potent and selective inhibitor of EZH2/1 with IC 50 s of <10 nM and 45 nM, repectively.
性状
Solid
IC50 & Target[1][2]
IC50: <10 nM (EZH2), 45 nM (EZH1)
体外研究(In Vitro)
UNC1999, the first orally bioavailable inhibitor that has high in vitro potency for wild-type and mutant EZH2 as well as EZH1, a closely related H3K27 methyltransferase that shares 96% sequence identity with EZH2 in their respective catalytic domains. UNC1999 is highly selective for EZH2 and EZH1 over a broad range of epigenetic and non-epigenetic targets, competitive with the cofactor SAM, and non-competitive with the peptide substrate. UNC1999 has Ki values of 4,700 nM, 65 nM, 300 nM, and 1,500 nM for sigma1, sigma2, histamine H3, and NET, respectively. NC1999 selectively kills DB cells, a DLBCL cell line with the EZH2 Y641N mutation. UNC1999 displays a concentration- and time-dependent inhibition of DB cell proliferation (EC50=633±101 nM (n=3)). has not independently confirmed the acc
体内研究(In Vivo)
A single intraperitoneal (IP) injection of UNC1999 at 15, 50, or 150 mg/kg achieved high C max (9,700-11,800 nM) and exhibited dose linearity in male Swiss albino mice. Both the 150 and 50 mg/kg IP doses resulted in the plasma concentrations of UNC1999 above its cellular IC 50 over the entire 24 h period while the 15 mg/kg IP dose led to the plasma concentrations of UNC1999 above its cellular IC 50 for approximately 12 h. We next examined whether UNC1999 is orally bioavailable and are pleased to find that a single 50 mg/kg oral dose of UNC1999 achieved high C max (4,700 nM) and good exposure levels in male Swiss albino mice. The plasma concentrations of UNC1999 are maintained above its cellular IC 50 for approximately 20 h following this single oral dose. It is worth noting that all doses including the 150 mg/kg IP dose are wel
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Konze KD, et al. An Orally Bioavailable Chemical Probe of the Lysine Methyltransferases EZH2 and EZH1. ACS Chem Biol. 2013;8(6):1324-34.
溶解度数据
In Vitro: DMSO : 100 mg/mL (175.52 mM; Need ultrasonic)H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 80°C) (insoluble)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

相关产品

更多
The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2